CME's lawsuit over crypto perpetual futures may be headed for an early exit, though not on the merits. The CFTC has filed to dismiss the suit, arguing the exchange cannot claim competitive injury when it is already authorized to list those same contracts as a designated contract market. That framing, which the agency distilled to "much ado about nothing," is either a clean legal kill or a deflection from the harder regulatory question underneath.
The case for dismissal is legally compact. CME holds designated contract market status, and the CFTC's position is that this gives the exchange the same pathway to offer perp futures it is now contesting. If a plaintiff already has access to the market it claims to be locked out of, the agency argues, there is no cognizable injury and therefore no standing.
The counterargument has real weight, even if the standing logic cuts against CME. Formal access to a regulatory pathway and the competitive conditions that emerge when a rival gains approval under it are not the same thing. CME may contend that the injury is in the market structure that takes shape before it lists a single contract. Courts have sometimes found injury in the timing and circumstance of regulatory action, and that is the narrower argument standing doctrine would require CME to win.
On balance, the CFTC has reached for the most efficient tool available: challenge standing before the underlying questions about crypto perp futures regulation reach a judge. The line to watch is whether CME can articulate a theory of injury specific enough to clear that bar.